363 related articles for article (PubMed ID: 14648069)
1. Clinical applications of dendritic cell vaccination in the treatment of cancer.
Cranmer LD; Trevor KT; Hersh EM
Cancer Immunol Immunother; 2004 Apr; 53(4):275-306. PubMed ID: 14648069
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-based immunotherapy.
Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
4. Current issues in delivering DCs for immunotherapy.
Barratt-Boyes SM; Figdor CG
Cytotherapy; 2004; 6(2):105-10. PubMed ID: 15203986
[TBL] [Abstract][Full Text] [Related]
5. Optimizing dendritic cell-based immunotherapy for cancer.
Zhong H; Shurin MR; Han B
Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
[TBL] [Abstract][Full Text] [Related]
6. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters.
Engell-Noerregaard L; Hansen TH; Andersen MH; Thor Straten P; Svane IM
Cancer Immunol Immunother; 2009 Jan; 58(1):1-14. PubMed ID: 18719915
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products.
Nicolette CA; Healey D; Tcherepanova I; Whelton P; Monesmith T; Coombs L; Finke LH; Whiteside T; Miesowicz F
Vaccine; 2007 Sep; 25 Suppl 2():B47-60. PubMed ID: 17669561
[TBL] [Abstract][Full Text] [Related]
8. The use of dendritic cells for cancer vaccination.
Esche C; Shurin MR; Lotze MT
Curr Opin Mol Ther; 1999 Feb; 1(1):72-81. PubMed ID: 11249687
[TBL] [Abstract][Full Text] [Related]
9. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines for established cancer: how to make them better?
Andrews DM; Maraskovsky E; Smyth MJ
Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells and their role in cancer immunotherapy.
Jalili A
Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
[TBL] [Abstract][Full Text] [Related]
12. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-based cancer therapy.
Conrad C; Nestle FO
Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
[TBL] [Abstract][Full Text] [Related]
14. Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Tuyaerts S; Aerts JL; Corthals J; Neyns B; Heirman C; Breckpot K; Thielemans K; Bonehill A
Cancer Immunol Immunother; 2007 Oct; 56(10):1513-37. PubMed ID: 17503040
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell vaccination.
Proudfoot O; Pouniotis D; Sheng KC; Loveland BE; Pietersz GA
Expert Rev Vaccines; 2007 Aug; 6(4):617-33. PubMed ID: 17669014
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of dendritic cell vaccines.
Morse MA; Lyerly HK
Curr Opin Mol Ther; 2000 Feb; 2(1):20-8. PubMed ID: 11249649
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell immunotherapy: mapping the way.
Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
[TBL] [Abstract][Full Text] [Related]
19. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
Antonia SJ; Mirza N; Fricke I; Chiappori A; Thompson P; Williams N; Bepler G; Simon G; Janssen W; Lee JH; Menander K; Chada S; Gabrilovich DI
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):878-87. PubMed ID: 16467102
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunotherapy with dendritic cells in cancer: current status.
Nencioni A; Brossart P
Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
